Keymed Biosciences, Inc. (2162) Income Statement

Last quarter (Q2 2025), Keymed Biosciences, Inc.'s total revenue was ¥498.75M, an increase of 52.47% from the same quarter last year. In Q2, Keymed Biosciences, Inc.'s net income was ¥-78.84M. See Keymed Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.